Identification of multi-drug resistant Pseudomonas aeruginosa clinical isolates that are highly disruptive to the intestinal epithelial barrier
2006

Study on Multi-Drug Resistant Pseudomonas aeruginosa and Intestinal Barrier Disruption

Sample size: 31 publication Evidence: moderate

Author Information

Author(s): Zaborina Olga, Kohler Jonathan E, Wang Yingmin, Bethel Cindy, Shevchenko Olga, Wu Licheng, Turner Jerrold R, Alverdy John C

Primary Institution: University of Chicago

Hypothesis

How do multi-drug resistant Pseudomonas aeruginosa clinical isolates affect the integrity of the intestinal epithelial barrier?

Conclusion

The study found that most multi-drug resistant Pseudomonas aeruginosa strains were less effective at disrupting the intestinal barrier, but certain genotypes posed a significant risk for severe infections.

Supporting Evidence

  • Most strains were less effective at disrupting the intestinal barrier.
  • Three distinct genotypes were identified that could significantly disrupt the barrier.
  • The presence of the exoU gene was associated with higher virulence.

Takeaway

Some bad germs can hurt our tummy's protective layer, but not all of them are strong enough to do it.

Methodology

The study screened clinical strains of Pseudomonas aeruginosa for their ability to disrupt human intestinal epithelial cells and correlated findings with virulence traits.

Potential Biases

Potential bias in strain selection and environmental factors affecting results.

Limitations

The study focused only on specific strains and may not represent all multi-drug resistant Pseudomonas aeruginosa.

Participant Demographics

Clinical strains obtained from patients in an intensive care unit.

Statistical Information

P-Value

p<0.0001

Statistical Significance

p<0.0001

Digital Object Identifier (DOI)

10.1186/1476-0711-5-14

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication